A large-scale coronavirus vaccine study delivered promising results. US drugmaker Pfizer (+7.7%) and its German partner BioNTech (+13.9%) said data from the trial of their vaccine showed it was more than 90% effective in preventing COVID-19.
Subscribe to Our Newsletter
Get daily updates straight to your inbox.